Date
Webcast 
Presentation
Speaker
11/14/19Q3 2019 EarningsPDF

Udit Batra

Marcus Kuhnert

08/08/19Q2 2019 EarningsPDF

Stefan Oschmann

Marcus Kuhnert

06/14/19R&D Update CallPDF

Luciano Rossetti

Rehan Verjee

05/14/19Q1 2019 EarningsPDF

Marcus Kuhnert

Belen Garijo

04/12/19Acquisition of Versum MaterialsPDFMarcus Kuhnert
04/01/19FDA approval on Mavenclad in USPDF

Rehan Verjee

Luciano Rossetti

John Walsh

03/07/19Q4/FY 2018 EarningsPDF

Stefan Oschmann

Marcus Kuhnert

02/27/19Versum acquisision proposalPDF

Stefan Oschmann

Marcus Kuhnert

02/05/19M7824 Merck KGaA, Darmstadt, Germany & GSK AlliancePDF

Stefan Oschmann

Belen Garijo

Marcus Kuhnert